This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1996-1998.
Company Filing History:
Years Active: 1996-1998
Title: Jacek Krzeminski: Innovator in Cancer Research
Introduction
Jacek Krzeminski is a notable inventor based in Bronxville, NY (US). He has made significant contributions to the field of cancer research through his innovative work and patents. With a total of two patents to his name, he continues to push the boundaries of scientific discovery.
Latest Patents
Krzeminski's latest patents include the development of 2'-'up' fluorinated 2'-deoxy-arabinofuranosylpurines. This invention provides a compound with a specific structure, wherein R.sup.1 can be hydrogen, benzyl, or a substituted benzyl group. Additionally, he has patented the synthesis of 2'-'up' fluorinated 2'-deoxy-arabinofuranosyl purines, which also features a similar structural composition.
Career Highlights
Krzeminski is affiliated with the Sloan-Kettering Institute for Cancer Research, where he applies his expertise to advance cancer treatment methodologies. His work is instrumental in developing new compounds that may lead to more effective therapies.
Collaborations
Throughout his career, Krzeminski has collaborated with esteemed colleagues, including Kyoichi A Watanabe and Krzysztof W Pankiewicz. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
Jacek Krzeminski is a dedicated inventor whose work in cancer research is marked by innovation and collaboration. His contributions through patents reflect his commitment to advancing medical science and improving patient outcomes.